APPLICATION
ANDA205205
TYPE
ANDA
ORIGINAL APPROVAL
2024-01-19
LATEST ACTION
2024-01-19
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED RELEASE
MARKETING STATUS
Prescription
Products
DEXLANSOPRAZOLEPrescription
DEXLANSOPRAZOLE 60MG · CAPSULE, DELAYED RELEASE · ORAL
DEXLANSOPRAZOLEPrescription
DEXLANSOPRAZOLE 30MG · CAPSULE, DELAYED RELEASE · ORAL
Approval history
2024-01-19UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.